Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Forbius to Present at Jefferies 2019 London Healthcare Conference


Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced today that Forbius management will present a company overview at the Jefferies 2019 Healthcare Conference on Thursday, November 21, 2019 at 07:20 a.m. GMT in London.

About Forbius: Targeting TGF-beta and EGFR Pathways in Fibrosis and Cancer

Forbius is a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer. We are focused on the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways.

Forbius' team of TGF-beta biology experts designed a proprietary platform of TGF-beta inhibitors with best-in-class potency and selectivity against the principal disease-driving isoforms 1 & 3. This novel class of TGF-beta inhibitors has proven highly active in preclinical models of fibrosis and cancer and was well-tolerated in long-term toxicology studies. Forbius' lead TGF-beta 1 & 3 inhibitor, AVID200, is undergoing Phase 1 clinical trials in two fibrotic indications as well as in solid tumors.

Forbius' lead program targeting EGFR is AVID100. AVID100 is an anti-EGFR antibody-drug conjugate (ADC) with a novel tumor-selective mode of action. This program is undergoing Phase 2a clinical trials in EGFR-overexpressing solid tumors.

About TGF-beta 1 & 3

TGF-beta 1 & 3 are the main oncogenic TGF-beta isoforms expressed by many solid tumors. They are believed to play a major role in T-cell suppression, fibrosis and resistance to anti-PD-(L)1 therapies such as nivolumab (Opdivo®) and pembrolizumab (Keytruda®) (Chakravarthy et al., Nature Comm., 2018; Tauriello et al., Nature, 2018; Mariathasan et al., Nature, 2018).


These press releases may also interest you

at 10:00
White Knight Press has just released Photographer's Guide to the Nikon Coolpix P950, a full-color, detailed guide book covering the menus, features, controls, and operation of the Nikon Coolpix P950 superzoom camera. This book, by Alexander S. White,...

at 08:05
Incyte today announced the first presentation of Phase 3 data for ruxolitinib cream in atopic dermatitis at the Revolutionizing Atopic Dermatitis Virtual Symposium. The Phase 3 TRuE-AD program, which includes the TRuE-AD1 and TRuE-AD2 studies, is...

at 08:00
As people in America and around the world continue to practice safety within their homes; in an effort to control the spread of this virus we present to you a Def Comedy Jam in support of communities in need during this COVID-19 Public Health Crisis,...

at 07:00
Plataine, a leading provider of Industrial IoT (IIoT) and AI-based software for advanced manufacturing optimization, is excited to announce that it joined the membership network of The National Composites Centre (NCC), the UK research center...

4 avr 2020
Womply, a software and API company serving small businesses and app developers, today announced that it is helping American small businesses get faster access to Paycheck Protection Program loans as a verified loan agent for multiple SBA 7(a)...

4 avr 2020
Ex-Formula 1 stars Rubens Barrichello and Jan Magnussen plus esports racer Kevin Siggy were the big winners in today's Legends Trophy esports races and The Race All-Star Cup - Fully Charged by ROKiT Phones. The...



News published on 18 november 2019 at 07:05 and distributed by: